# DESCRIPTION

## TECHNICAL FIELD

- define technical field

## BACKGROUND OF THE INVENTION

- introduce cancer immunotherapy
- describe limitations of ICB therapy
- motivate TAMs as targets
- summarize TAM biology

## SUMMARY OF THE INVENTION

- introduce MAO-A
- describe MAO-A induction in TAMs
- summarize MAO-A-deficient mice results
- describe MAOI treatment effects
- summarize clinical data correlation
- describe MAO-A's role in TAM polarization
- outline invention embodiments

## DETAILED DESCRIPTION OF THE INVENTION

- introduce MAO-A enzyme and its functions
- motivate MAO-A inhibitors for cancer immunotherapy
- describe MAO-A as an immune checkpoint
- introduce compositions of matter with MAOI and chemotherapeutic agent
- specify MAOI in the composition
- describe nanoparticle embodiments for MAOI delivery
- detail liposome composition and preparation
- introduce crosslinked multilamellar liposome embodiment
- describe targeting agents for nanoparticles
- characterize MAOI nanocarriers
- describe biological activity of nMAOIs
- specify amounts of MAOI in the composition
- introduce chemotherapeutic agents for combination therapy
- describe pharmaceutical dosage forms for administration
- introduce method of modulating TAM phenotype
- describe method of treating cancer with MAOI
- specify administration of MAOI with chemotherapeutic agent
- discuss dosing and pharmacology of MAOIs

### Results

- introduce MAO-A-deficient mice experiment
- analyze TAM gene expression profiles
- study role of MAO-A in antitumour immunity
- investigate MAO-A direct regulation of TAM polarization
- demonstrate MAO-A influence on T cell antitumour reactivity

### MAO-A Promotes Macrophage Immunosuppressive Polarization

- study MAO-A regulation of macrophage polarization

### MAO-A Promotes Macrophage Immunosuppressive Polarization Via ROS Upregulation

- investigate ROS role in macrophage immunosuppressive features
- measure ROS levels in TAMs and BMDMs
- study MAO-A regulation of ROS levels and JAK-Stat6 signaling pathway

### MAO-A Blockade for Cancer Immunotherapy-Syngeneic Mouse Tumour Model Studies

- study MAO-A blockade effect on TAM polarization and tumour growth
- evaluate MAO-A blockade as monotherapy and combination therapy
- analyze tumour suppression efficacy and immunomodulation

### MAO-A Blockade for Cancer Immunotherapy-Human TAM and Clinical Data Correlation Studies

- study MAO-A regulation of human macrophage polarization
- analyze MAOA gene expression in human TAMs
- evaluate MAO-A blockade effect on human TAM reprogramming
- study MAO-A blockade effect on human T cell antitumour reactivity
- conduct clinical data correlation studies on MAOA expression and patient survival
- analyze MAOA expression and PD-1 treatment outcome correlation

## DISCUSSION

- propose intratumoural MAO-A-ROS axis model
- motivate resemblance between brain and immune systems
- summarize TAM-targeting strategies in cancer therapy
- introduce MAO-A as new drug target for TAM repolarization
- discuss repurposing MAOIs for cancer immunotherapy
- highlight potential of MAOI treatment in combination cancer therapies
- suggest future research directions for MAO-A in immune regulation

## Methods

### Mice

- describe mouse strains and maintenance

### Human Tumour Samples

- describe human ovarian cancer tumour sample collection

### Cell Lines and Viral Vectors

- describe cell lines and viral vectors used

### Syngeneic Mouse Tumour Models

- describe syngeneic mouse tumour models

### Bone Marrow (BM) Transfer Mouse Tumour Model

- describe BM transfer mouse tumour model

### Syngeneic Mouse Tumour-TAM Co-Inoculation Model

- describe syngeneic mouse tumour-TAM co-inoculation model

### Xenograft Human Tumour-TAM Co-Inoculation Model

- describe xenograft human tumour-TAM co-inoculation model

### Tumour-Infiltrating Immune Cell (TII) Isolation and Analysis

- describe TII isolation and analysis

### Mouse Bone Marrow-Derived Macrophages (BMDM) Culture and Polarization

- describe BMDM culture
- describe BMDM polarization
- describe MAOI treatment
- describe H2O2 treatment
- describe tyramine treatment
- describe macrophage suppressive function assay
- describe MIG-Maoa retroviral vector construction
- describe macrophage transduction

## Reagents

- list reagents and their sources

### Flow Cytometry

- describe flow cytometry method
- list antibodies and dyes used

### Western Blot (WB)

- describe western blot method

### Quantitative Real-Time PCR (QPCR)

- describe QPCR method

### Reactive Oxygen Species (ROS) Measurement

- describe ROS measurement method
- list reagents used
- describe flow cytometry analysis

### Tumour Immune Dysfunction and Exclusion (TIDE) Computational Method

- describe TIDE computational method

### Statistical Analysis

- specify statistical methods
- cite prior art
- discuss immune checkpoint inhibition
- discuss tumour-associated macrophages
- discuss macrophage diversity and function
- discuss macrophage regulation of tumour growth
- discuss immunosuppressive subsets of macrophages
- discuss modulation of T-cell metabolism
- discuss monoamine oxidase and its role in disease
- list references
- describe oxidative stress and macrophage activation
- discuss role of IL-4 and STAT6 in macrophage activation
- explain JAK/STAT signaling and its regulation by ROS
- summarize MAO inhibitors and their effects on immune cells
- discuss cancer immunotherapy and immune cell dysfunction
- describe gene signatures predicting cancer treatment outcomes
- discuss neurotransmitters and neurochemicals as immune modulators

